ACTIVITIES

GMP manufacture of the ShigETEC vaccine and evaluation of vaccine stability

The ShigETEC vaccine will be generated by fermentation under cGMP (current Good Manufacturing Practice) condition and the viability and stability of the ShigETEC vaccine will be determined. After release according to GMP requirements, the ShigETEC vaccine will be shipped to the clinical trial sites.  

Partner involved